Daratumumab improves depth of response and progression free survival in transplant-ineligible, high-risk, newly diagnosed multiple myeloma (NDMM)

被引：0

作者：

Jakubowiak, Andrzej ^{[1
]}

Kumar, Shaji ^{[2
]}

Medhekar, Rohan ^{[3
]}

Pei, Huiling ^{[3
]}

Lefebvre, Patrick ^{[4
]}

Kaila, Shuchita ^{[3
]}

He, Jianming ^{[3
]}

Lafeuille, Marie-Helene ^{[4
]}

Cortoos, Annelore ^{[5
]}

Londhe, Anil ^{[6
]}

Mavros, Panagiotis ^{[3
]}

Lin, Thomas ^{[5
]}

Usmani, Saad Z.

机构：

[1] Univ Chicago, Chicago, IL USA

[2] Mayo Clin Rochester, Dept Hematol, Rochester, MN USA

[3] Janssen Sci Affairs LLC, Titusville, NJ USA

[4] Anal Grp Inc, Horsham, PA USA

[5] Janssen Sci Affairs LLC, Horsham, PA USA

[6] Levine Canc Inst Atrium Hlth, Charlotte, NC USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OAB-002

引用

页码：S2 / S2

页数：1